COVID-19 dengan Komorbid Tuberkulosis Paru dan Diabetes Melitus

  • Muthia Faurin Fakultas Kedokteran Universitas Andalas
  • Fauzar Fauzar Fakultas Kedokteran Universitas Andalas
  • Roza Kurniati Fakultas Kedokteran Universitas Andalas
  • Alexander Kam Fakultas Kedokteran Universitas Andalas
  • Eva Decroli Fakultas Kedokteran Universitas Andalas
DOI: https://doi.org/10.25077/jikesi.v1i3.466
Keywords: COVID-19, pulmonary tuberculosis, diabetes mellitus

Abstract

A 61-year-old man was admitted a confirmed COVID-19 with comorbid pulmonary tuberculosis and type 2 diabetes mellitus. The patient was given favipiravir therapy, category 1 of antituberculosis drug, and insulin therapy. The patient responded well to therapy with improved clinical and laboratory indicators.

Key words: COVID-19, pulmonary tuberculosis, diabetes mellitus

Published
2021-05-24
Issue
Vol 1 No 3 (2020): November 2020
Section
Case Report

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.